RECENTLY APPROVED A BLOOD TEST AS A SCREENING FOR ADULTS WHO ARE AT RISK FOR COLORECTAL CANCER. SOME EXPERTS SAY THIS IS A GAME CHANGER AS THIS TYPE OF CANCER IS VERY TREATABLE IF IT’S CAUGHT IN TIME.

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

INDIANAPOLIS (WISH) – This week, the United States Food and Drug Administration approved Guardant’s Shield blood test to screen for colon cancer in average-risk Americans 45 to 75 years old.

Colon cancer, also known as colorectal cancer, is the third-most common cancer worldwide, affecting millions each year. However, the good news is that with early detection through regular screening, ...

Colon Cancer Screening: The test could increase the number of patients who receive screening for colorectal cancer. The Food and Drug Administration (FDA) has approved a new colorectal cancer (CRC) ...

An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing kit in the mail without ordering it yourself: your doctor or health care ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...